Regeneron Pharmaceuticals (NASDAQ:REGN) Receives New Coverage from Analysts at Evercore ISI tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nineteen research firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and fourteen have given a […]
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,020 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as $943.27 and last traded at $940.63, with a volume of 229081 shares traded. The stock had previously closed at $933.40. Wall Street Analysts Forecast Growth Several research analysts have […]